A detailed history of Iron Horse Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Iron Horse Wealth Management, LLC holds 21 shares of VRTX stock, worth $9,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 11 90.91%
Holding current value
$9,755
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$460.0 - $505.78 $4,600 - $5,057
10 Added 90.91%
21 $9,000
Q3 2023

Oct 18, 2023

BUY
$338.18 - $362.46 $3,719 - $3,987
11 New
11 $3,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Iron Horse Wealth Management, LLC Portfolio

Follow Iron Horse Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Horse Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Horse Wealth Management, LLC with notifications on news.